{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:37:57Z","timestamp":1787315877914,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2018-06209"],"award-info":[{"award-number":["RGPIN-2018-06209"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPN-2016-06532"],"award-info":[{"award-number":["RGPN-2016-06532"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RPGIN-2023-04469"],"award-info":[{"award-number":["RPGIN-2023-04469"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["172765"],"award-info":[{"award-number":["172765"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000193","name":"International Development Research Centre","doi-asserted-by":"publisher","award":["108517"],"award-info":[{"award-number":["108517"]}],"id":[{"id":"10.13039\/501100000193","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.vaccine.2024.02.063","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T10:28:48Z","timestamp":1709893728000},"page":"2144-2149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Intranasal delivery of a self-adjuvanted nanovaccine composed of the curli filaments and the highly conserved M2e epitope confers protection against influenza a virus in mice"],"prefix":"10.1016","volume":"42","author":[{"given":"Philippe","family":"St-Louis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5563-8787","authenticated-orcid":false,"given":"Steve","family":"Bourgault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Archambault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.02.063_b0005","unstructured":"CIHI. Hospitalizations for COVID-19 among Canada\u2019s youngest surged by more than 600% in the second year of the pandemic. 2023 [cited 2023 January 7]."},{"key":"10.1016\/j.vaccine.2024.02.063_b0010","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev-biodatasci-020722-041304","article-title":"Challenges and progress in designing broad-spectrum vaccines against rapidly mutating viruses","volume":"6","author":"Bedi","year":"2023","journal-title":"Annu Rev Biomed Data Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2024.02.063_b0015","first-page":"202","article-title":"Intranasal HD-ad vaccine protects the upper and lower respiratory tracts of hACE2 mice against SARS-CoV-2","volume":"11","author":"Cao","year":"2021","journal-title":"CellBiosci"},{"key":"10.1016\/j.vaccine.2024.02.063_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121180","article-title":"Intranasal vaccine: factors to consider in research and development","volume":"609","author":"Xu","year":"2021","journal-title":"Int J Pharm"},{"issue":"11","key":"10.1016\/j.vaccine.2024.02.063_b0025","article-title":"Vaccination strategies based on bacterial self-assembling proteins as antigen delivery nanoscaffolds","volume":"10","author":"Lamontagne","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2024.02.063_b0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fimmu.2019.00022","article-title":"Nanoparticle-based vaccines against respiratory viruses","volume":"10","author":"Al-Halifa","year":"2019","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2024.02.063_b0035","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/s41385-022-00528-5","article-title":"Trained immunity of alveolar macrophages requires metabolic rewiring and type 1 interferon signaling","volume":"15","author":"Zahalka","year":"2022","journal-title":"Mucosal Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2024.02.063_b0040","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41590-019-0583-y","article-title":"Training the trainable cells of the immune system and beyond","volume":"21","author":"Kar","year":"2020","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2024.02.063_b0045","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1021\/nn4006544","article-title":"Biomimetic antigenic nanoparticles elicit controlled protective immune response to influenza","volume":"7","author":"Patterson","year":"2013","journal-title":"ACS Nano"},{"issue":"21","key":"10.1016\/j.vaccine.2024.02.063_b0050","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202300224","article-title":"Engineered curli nanofilaments as a self-adjuvanted antigen delivery platform","volume":"12","author":"Lamontagne","year":"2023","journal-title":"Adv Healthc Mater"},{"issue":"6","key":"10.1016\/j.vaccine.2024.02.063_b0055","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1021\/acs.molpharmaceut.0c01256","article-title":"Toll-like receptor-4 (TLR4) agonist-based intranasal nanovaccine delivery system for inducing systemic and mucosal immunity","volume":"18","author":"Bakkari","year":"2021","journal-title":"Mol Pharm"},{"key":"10.1016\/j.vaccine.2024.02.063_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120672","article-title":"Self-assembled peptide nanorod vaccine confers protection against influenza a virus","volume":"269","author":"Zottig","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.vaccine.2024.02.063_b0065","article-title":"Harvesting murine alveolar macrophages and evaluating cellular activation induced by polyanhydride nanoparticles","volume":"64","author":"Chavez-Santoscoy","year":"2012","journal-title":"J Vis Exp"},{"issue":"1","key":"10.1016\/j.vaccine.2024.02.063_b0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12929-018-0433-5","article-title":"Flagellin-fused protein targeting M2e and HA2 induces potent humoral and T-cell responses and protects mice against various influenza viruses a subtypes","volume":"25","author":"Stepanova","year":"2018","journal-title":"J Biomed Sci"},{"issue":"66","key":"10.1016\/j.vaccine.2024.02.063_b0075","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abj5129","article-title":"Intranasal priming induces local lung-resident B cell populations that secrete protective mucosal antiviral IgA","volume":"6","author":"Oh","year":"2021","journal-title":"Sci Immunol"},{"issue":"6179","key":"10.1016\/j.vaccine.2024.02.063_b0080","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/334255a0","article-title":"Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells","volume":"334","author":"Stevens","year":"1988","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.vaccine.2024.02.063_b0085","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/eji.201040391","article-title":"IL-6: regulator of Treg\/Th17 balance","volume":"40","author":"Kimura","year":"2010","journal-title":"Eur J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2024.02.063_b0090","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.4049\/jimmunol.0900237","article-title":"Cutting edge: lung mucosal Th17-mediated responses induce polymeric ig receptor expression by the airway epithelium and elevate secretory IgA levels","volume":"182","author":"Jaffar","year":"2009","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2024.02.063_b0095","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/cyto.a.24509","article-title":"OMIP-079: cell cycle of CD4(+) and CD8(+) na\u00efve\/memory T cell subsets, and of treg cells from mouse spleen","volume":"99","author":"Natalini","year":"2021","journal-title":"Cytometry A"},{"issue":"2","key":"10.1016\/j.vaccine.2024.02.063_b0100","doi-asserted-by":"crossref","first-page":"374","DOI":"10.4049\/jimmunol.1800979","article-title":"Memory T cell dynamics in the lung during influenza virus infection","volume":"202","author":"Pizzolla","year":"2019","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24002226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24002226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T15:30:05Z","timestamp":1723044605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24002226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0264410X24002226"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.02.063","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal delivery of a self-adjuvanted nanovaccine composed of the curli filaments and the highly conserved M2e epitope confers protection against influenza a virus in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.02.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}